ANALYSIS OF ADVERSE DRUG REACTION REPORT FORMS ON THE MEDICINES, USED FOR AIDS TREATMENT (REGISTERED IN THE REPUBLIC OF CRIMEA IN THE PERIOD FROM 2011 TO 2016)

According to the data of the World Health Organization (WHO), human immunodeficiency virus (HIV) remains a major global public health problem.The main method of treating HIV is using highly active antiretroviral therapy (HAART), which is the use of multiple medicines acting on different viral target...

Full description

Bibliographic Details
Main Authors: A. V. Matveev, A. Е. Krasheninnikov, E. A. Egorova, E. I. Konyaeva
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2019-01-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
Online Access:https://www.pharmpharm.ru/jour/article/view/343
_version_ 1797874733787643904
author A. V. Matveev
A. Е. Krasheninnikov
E. A. Egorova
E. I. Konyaeva
author_facet A. V. Matveev
A. Е. Krasheninnikov
E. A. Egorova
E. I. Konyaeva
author_sort A. V. Matveev
collection DOAJ
description According to the data of the World Health Organization (WHO), human immunodeficiency virus (HIV) remains a major global public health problem.The main method of treating HIV is using highly active antiretroviral therapy (HAART), which is the use of multiple medicines acting on different viral targets. The timely onset of HAART can suppress the replication of the virus in the human body and helps to strengthen its immune system and restore its ability to fight infections. At the same time, the choice of medicines to improve the quality of life and patients’ compliance during antiretroviral therapy should be based on their effectiveness and safety. The aim of this research was to analyze and study the adverse reactions that occur in patients with HIV living in the territory of the Republic of Crimea, when using HAART.Materials and methods. The objects of research were 274 report cards about the adverse reactions, registered in the regional base (registry) of spontaneous messages called ARCADe (Adverse Reactions in Crimea, Autonomic Database) for the period from 2011 to 2016.Results. The results of the study showed that the most often adverse reactions were observed when using medicines of the group of Nucleoside Reverse Transcriptase Inhibitors (NRTI). This is explained by the inclusion of NRTI medicines as the main medicine in the method of HAART. Efavirenz (EFV) and Nevirapine (NVP) were absolute leaders among these groups of antiretroviral medicines. Among the combined antiviral medicines active against HIV, the most frequently adverse reactions were associated with the use of a combination of Lamivudine (3TC) and Zidovudine (ZDV). The main clinical manifestations of adverse reactions in the use of combination medicines for treating HIV were a decrease in the level of hemoglobin and the development of anemia. At the same time, in 85% of cases, the patients needed medication in order to correct the resulting adverse drug reaction (ADR). The combination of antiretroviral therapy has often been associated with the development of serious ADR. In case of monotherapy, the main clinical manifestations of adverse reactions were disorders of the central nervous system (dizziness, hallucinations, sleep disorders) and allergic reactions of varying severity (including 1 case of angioedema to “Eferven” (Efavirenz (EFV)),600 mg). Hereby, in almost half of the cases, the usage of antiretroviral medicines of the NRTI group and protease inhibitors caused the development of serious side effects. This confirms the necessity to study and analyze adverse reactions in order to increase the safety of patients’ pharmacotherapy and improve their quality of life.Conclusion. The study of adverse reactions to the medicines used for treatment of HIV is of a paramount importance in improving the safety and compliance of HIV patients to lifelong pharmacotherapy.
first_indexed 2024-04-10T01:35:35Z
format Article
id doaj.art-1c86b84e41e9495080a7866bebd63434
institution Directory Open Access Journal
issn 2307-9266
2413-2241
language Russian
last_indexed 2024-04-10T01:35:35Z
publishDate 2019-01-01
publisher Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute
record_format Article
series Фармация и фармакология (Пятигорск)
spelling doaj.art-1c86b84e41e9495080a7866bebd634342023-03-13T09:18:12ZrusVolgograd State Medical University, Pyatigorsk Medical and Pharmaceutical InstituteФармация и фармакология (Пятигорск)2307-92662413-22412019-01-016656858310.19163/2307-9266-2018-6-6-568-583290ANALYSIS OF ADVERSE DRUG REACTION REPORT FORMS ON THE MEDICINES, USED FOR AIDS TREATMENT (REGISTERED IN THE REPUBLIC OF CRIMEA IN THE PERIOD FROM 2011 TO 2016)A. V. Matveev0A. Е. Krasheninnikov1E. A. Egorova2E. I. Konyaeva3Национальный научный центр Фармаконадзора, Автономная некоммерческая организация; Медицинская академия им. С.И. Георгиевского, ФГАОУ ВО КФУ им. В.И. ВернадскогоНациональный научный центр Фармаконадзора, Автономная некоммерческая организацияМедицинская академия им. С.И. Георгиевского, ФГАОУ ВО КФУ им. В.И. ВернадскогоМедицинская академия им. С.И. Георгиевского, ФГАОУ ВО КФУ им. В.И. ВернадскогоAccording to the data of the World Health Organization (WHO), human immunodeficiency virus (HIV) remains a major global public health problem.The main method of treating HIV is using highly active antiretroviral therapy (HAART), which is the use of multiple medicines acting on different viral targets. The timely onset of HAART can suppress the replication of the virus in the human body and helps to strengthen its immune system and restore its ability to fight infections. At the same time, the choice of medicines to improve the quality of life and patients’ compliance during antiretroviral therapy should be based on their effectiveness and safety. The aim of this research was to analyze and study the adverse reactions that occur in patients with HIV living in the territory of the Republic of Crimea, when using HAART.Materials and methods. The objects of research were 274 report cards about the adverse reactions, registered in the regional base (registry) of spontaneous messages called ARCADe (Adverse Reactions in Crimea, Autonomic Database) for the period from 2011 to 2016.Results. The results of the study showed that the most often adverse reactions were observed when using medicines of the group of Nucleoside Reverse Transcriptase Inhibitors (NRTI). This is explained by the inclusion of NRTI medicines as the main medicine in the method of HAART. Efavirenz (EFV) and Nevirapine (NVP) were absolute leaders among these groups of antiretroviral medicines. Among the combined antiviral medicines active against HIV, the most frequently adverse reactions were associated with the use of a combination of Lamivudine (3TC) and Zidovudine (ZDV). The main clinical manifestations of adverse reactions in the use of combination medicines for treating HIV were a decrease in the level of hemoglobin and the development of anemia. At the same time, in 85% of cases, the patients needed medication in order to correct the resulting adverse drug reaction (ADR). The combination of antiretroviral therapy has often been associated with the development of serious ADR. In case of monotherapy, the main clinical manifestations of adverse reactions were disorders of the central nervous system (dizziness, hallucinations, sleep disorders) and allergic reactions of varying severity (including 1 case of angioedema to “Eferven” (Efavirenz (EFV)),600 mg). Hereby, in almost half of the cases, the usage of antiretroviral medicines of the NRTI group and protease inhibitors caused the development of serious side effects. This confirms the necessity to study and analyze adverse reactions in order to increase the safety of patients’ pharmacotherapy and improve their quality of life.Conclusion. The study of adverse reactions to the medicines used for treatment of HIV is of a paramount importance in improving the safety and compliance of HIV patients to lifelong pharmacotherapy.https://www.pharmpharm.ru/jour/article/view/343нежелательные реакцииантиретровирусные препаратыингибиторы обратной транскриптазывич-инфекция
spellingShingle A. V. Matveev
A. Е. Krasheninnikov
E. A. Egorova
E. I. Konyaeva
ANALYSIS OF ADVERSE DRUG REACTION REPORT FORMS ON THE MEDICINES, USED FOR AIDS TREATMENT (REGISTERED IN THE REPUBLIC OF CRIMEA IN THE PERIOD FROM 2011 TO 2016)
Фармация и фармакология (Пятигорск)
нежелательные реакции
антиретровирусные препараты
ингибиторы обратной транскриптазы
вич-инфекция
title ANALYSIS OF ADVERSE DRUG REACTION REPORT FORMS ON THE MEDICINES, USED FOR AIDS TREATMENT (REGISTERED IN THE REPUBLIC OF CRIMEA IN THE PERIOD FROM 2011 TO 2016)
title_full ANALYSIS OF ADVERSE DRUG REACTION REPORT FORMS ON THE MEDICINES, USED FOR AIDS TREATMENT (REGISTERED IN THE REPUBLIC OF CRIMEA IN THE PERIOD FROM 2011 TO 2016)
title_fullStr ANALYSIS OF ADVERSE DRUG REACTION REPORT FORMS ON THE MEDICINES, USED FOR AIDS TREATMENT (REGISTERED IN THE REPUBLIC OF CRIMEA IN THE PERIOD FROM 2011 TO 2016)
title_full_unstemmed ANALYSIS OF ADVERSE DRUG REACTION REPORT FORMS ON THE MEDICINES, USED FOR AIDS TREATMENT (REGISTERED IN THE REPUBLIC OF CRIMEA IN THE PERIOD FROM 2011 TO 2016)
title_short ANALYSIS OF ADVERSE DRUG REACTION REPORT FORMS ON THE MEDICINES, USED FOR AIDS TREATMENT (REGISTERED IN THE REPUBLIC OF CRIMEA IN THE PERIOD FROM 2011 TO 2016)
title_sort analysis of adverse drug reaction report forms on the medicines used for aids treatment registered in the republic of crimea in the period from 2011 to 2016
topic нежелательные реакции
антиретровирусные препараты
ингибиторы обратной транскриптазы
вич-инфекция
url https://www.pharmpharm.ru/jour/article/view/343
work_keys_str_mv AT avmatveev analysisofadversedrugreactionreportformsonthemedicinesusedforaidstreatmentregisteredintherepublicofcrimeaintheperiodfrom2011to2016
AT aekrasheninnikov analysisofadversedrugreactionreportformsonthemedicinesusedforaidstreatmentregisteredintherepublicofcrimeaintheperiodfrom2011to2016
AT eaegorova analysisofadversedrugreactionreportformsonthemedicinesusedforaidstreatmentregisteredintherepublicofcrimeaintheperiodfrom2011to2016
AT eikonyaeva analysisofadversedrugreactionreportformsonthemedicinesusedforaidstreatmentregisteredintherepublicofcrimeaintheperiodfrom2011to2016